NEFL and Alzheimer disease: Apart from Aβ and tau biomarkers, blood-based indicators of neurodegeneration in AD include total tau, GFAP, and neurofilament light chain (NfL), reflecting neuronal injury, CNS inflammation, and subcortical axonal damage, respectively.